Clinical trial
Sex Related Outcomes in Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus: A 12-month Real-world Study
NCT07056803 is registered in ClinicalTrials.gov with University of Palermo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sex Related Outcomes in Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus: A 12-month Real-world Study
- Lead sponsor
- University of Palermo
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- June 25, 2025
- Enrollment
- 212 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus type 2